
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
EPS Corporation, a Shinjuku-ku, Tokyo-based CRO, has reached an agreement to offer CluePoints’ Risk Based Quality Management (RBQM) solutions to its sponsors. The RBQM tools will complement either new or existing RBM processes through the CluePoints Central Monitoring Platform to allow EPS sponsors drive early risk detection, improve quality and enhance patient safety in clinical trials.
For the full release, click






